Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-25T08:38:50.665Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuromuscular block and relative concentrations of mivacurium isomers under isoflurane versus propofol anaesthesia

Published online by Cambridge University Press:  11 July 2005

T. Ledowski ,
H. Wulf ,
K. Ahrens ,
M. Weindlmayr-Goettel ,
H.-G. Kress ,
G. Geldner  and
J. Scholz
T. Ledowski
Affiliation:
Hospital of the Christian-Albrechts-University, Department of Anaesthesiology and Intensive Care Medicine, Kiel, Germany
H. Wulf
Affiliation:
Hospital of the Philipps-University, Department of Anaesthesiology and Intensive Care Medicine, Marburg, Germany
K. Ahrens
Affiliation:
Hospital of the Philipps-University, Department of Anaesthesiology and Intensive Care Medicine, Marburg, Germany
M. Weindlmayr-Goettel
Affiliation:
University of Vienna, Department B of Anaesthesiology and General Intensive Care Medicine, Allgemeines Krankenhaus, Austria
H.-G. Kress
Affiliation:
University of Vienna, Department B of Anaesthesiology and General Intensive Care Medicine, Allgemeines Krankenhaus, Austria
G. Geldner
Affiliation:
Hospital of the Philipps-University, Department of Anaesthesiology and Intensive Care Medicine, Marburg, Germany
J. Scholz
Affiliation:
Hospital of the Christian-Albrechts-University, Department of Anaesthesiology and Intensive Care Medicine, Kiel, Germany
Get access

Extract

Summary

Background and objective: The augmentation of the effect of neuromuscular blocking drugs with volatile anaesthetics is well documented, but the mechanism remains unclear. The pharmacological interaction and relative plasma concentrations of mivacurium isomers were investigated during either propofol- or isoflurane-maintained anaesthesia.

Methods: Forty-four patients were randomly assigned to one of two groups: isoflurane or propofol. All patients received an initial dose of mivacurium 0.1 mg kg−1. After recovery of the first twitch (T1) response measured by acceleromyography to 5%, a T1 depression of 90–99% was maintained by infusion. After a steady state was reached, blood samples were taken after 10 and 30 min for analysis of mivacurium isomers. Recovery times for T1 to 25/50/75/90% (TW25–90), train-of-four ratio 25/70% and recovery index (time TW25–75) were recorded after stop of infusion.

Results: In the isoflurane group, lower infusion rates were needed (3.0 ± 1.6 versus 3.6 ± 1.6 μg kg−1 min−1) and there was a slower recovery (significant for train-of-four ratio 70%: 21.9 versus 17.9 min). The plasma concentrations of mivacurium and its trans–trans isomer (in percentage of the total) were significantly higher in the isoflurane group (10 min: 52.6 versus 25.8%; 30 min: 49.6 versus 23.2%).

Conclusions: For mivacurium, the phenomenon of ‘potentiation’ of the effect of muscle relaxants by volatile anaesthetics could be due to an increase in the plasma concentration of the potent trans–trans isomer.

Keywords

ANAESTHETICS, INHALATIONCHEMISTRY, ORGANIC, isomerismDRUG INTERACTIONSMETABOLISM, pharmacokineticsNEUROMUSCULAR NON-DEPOLARIZING AGENTS, mivacurium
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 20 , Issue 10 , November 2003 , pp. 821 - 825
Copyright
© 2003 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wulf H, Hauschild S, Proppe D, Ledowski T. Augmentation of the neuromuscular blocking effect of mivacurium during inhalation anesthesia with desflurane, sevoflurane and isoflurane in comparison with total intravenous anesthesia. Anaesthesiol Reanim 1998; 23: 88–92.Google Scholar
Miller RD, Way WL, Dolan WM, Stevens WC, Eger EI. The dependence of pancuronium and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and forane. Anesthesiology 1972; 37: 573–581.Google Scholar
Young AP, Sigman DS. Allosteric effects of volatile anesthetics on the membrane-bound acetylcholine receptor protein, Part 1. Mol Pharmacol 1981; 20: 498–505.Google Scholar
Waud BE, Waud DR. The effects of diethyl ether, enflurane and isoflurane at the neuromuscular junction. Anesthesiology 1975; 42: 275–280.Google Scholar
Hughes R, Payne JP. Interactions of halothane with nondepolarizing neuromuscular blocking drugs in man. Br J Clin Pharmacol 1979; 7: 485–490.Google Scholar
Waud BE, Waud DR. Effects of volatile anesthetics on directly and indirectly stimulated skeletal muscle. Anesthesiology 1979; 50: 103–110.Google Scholar
Miller RD, Crique M, Eger EI. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine. Anesthesiology 1976; 44: 206–210.Google Scholar
Rosenberg H. Sites and mechanisms of action of halothane on skeletal muscle function in vitro. Anesthesiology 1979; 50: 331–335.Google Scholar
Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1994; 80: 1296–1302.Google Scholar
Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59–74.Google Scholar
Weindlmayr-Goettel M, Weberhofer G, Gilly H, Kress HG. Improved HPLC assay for the determination of mivacurium in plasma. Br J Anaesth 1996; 76 (Suppl 2): A249.Google Scholar
De Mey CJ, Fonck K, Mareels K, Rolly G. The influence of isoflurane on a continuous infusion of mivacurium. Anaesthesia 1995; 50: 947–949.Google Scholar
Hart PS, McCarthy GJ, Brown R, Lau M, Fisher DM. The effect of plasma cholinesterase activity on mivacurium infusion rates. Anesth Analg 1995; 80: 760–763.Google Scholar
Ali HH, Savarese JJ, Embree PB, et al. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. Br J Anaesth 1988; 61: 541–546.Google Scholar
Goudsouzian N, Chakravorti S, Denman W, Schwartz A, Yang HS, Cook DR. Prolonged mivacurium infusion in young and elderly adults. Can J Anaesth 1997; 44: 955–962.Google Scholar
Shanks CA, Fragen RJ, Pemberton D, Kratz JA, Risner ME. Mivacurium-induced neuromuscular blockade following single bolus doses and with continuous infusion during either balanced or enflurane anesthesia. Anesthesiology 1989; 71: 362–366.Google Scholar
Powers DM, Brandom BW, Cook DR, et al. Mivacurium infusion during nitrous oxide–isoflurane anesthesia: comparison with nitrous oxide-opioid anesthesia. J Clin Anesth 1992; 4: 123–126.Google Scholar
Fragen RJ, Booij LHDJ, van der Pool F, Robertson EN, Crul JF. Interactions of diisopropyl phenol (ICI35868) with suxamethonium, vecuronium and pancuronium in vitro. Br J Anaesth 1983; 55: 433–436.Google Scholar